TCERG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.620800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.054800E-01
Normal-vs-Stage2
5.774000E-01
Normal-vs-Stage3
2.824400E-01
Normal-vs-Stage4
4.996600E-01
Stage1-vs-Stage2
8.994000E-01
Stage1-vs-Stage3
2.153800E-01
Stage1-vs-Stage4
9.174600E-01
Stage2-vs-Stage3
2.222600E-01
Stage2-vs-Stage4
9.861400E-01
Stage3-vs-Stage4
3.421400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.711200E-01
Normal-vs-AfricanAmerican
2.167200E-01
Normal-vs-Asian
3.642000E-01
Caucasian-vs-AfricanAmerican
2.749600E-01
Caucasian-vs-Asian
7.610600E-01
AfricanAmerican-vs-Asian
5.732200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.597200E-01
Normal-vs-Female
5.714200E-01
Male-vs-Female
8.583000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.698200E-01
Normal-vs-Age(41-60Yrs)
6.585200E-01
Normal-vs-Age(61-80Yrs)
5.236800E-01
Normal-vs-Age(81-100Yrs)
3.068600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.534800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.153000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.337400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.826000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.972000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.251400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.125200E-01
Normal-vs-Daily Drinker
4.699600E-01
Normal-vs-Weekly Drinker
3.350400E-01
Normal-vs-Occasional Drinker
5.977000E-01
Normal-vs-Social Drinker
6.763800E-01
Non Drinker-vs-Daily Drinker
3.843200E-01
Non Drinker-vs-Weekly Drinker
8.987800E-01
Non Drinker-vs-Occasional Drinker
8.733000E-01
Non Drinker-vs-Social Drinker
5.478800E-01
Daily Drinker-vs-Weekly Drinker
5.300600E-01
Daily Drinker-vs-Occasional Drinker
2.264600E-01
Daily Drinker-vs-Social Drinker
1.028190E-01
Weekly Drinker-vs-Occasional Drinker
7.725400E-01
Weekly Drinker-vs-Social Drinker
5.003800E-01
Occasional Drinker-vs-Social Drinker
5.741400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.092170E-01
Normal-vs-Grade 2
2.736200E-03
Normal-vs-Grade 3
1.965880E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.295220E-01
Grade 1-vs-Grade 3
1.047620E-01
Grade 1-vs-Grade 4
1.092170E-01
Grade 2-vs-Grade 3
7.060800E-01
Grade 2-vs-Grade 4
2.736200E-03
Grade 3-vs-Grade 4
1.965880E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.830400E-01
Normal-vs-NonDiabetic
5.803600E-01
Diabetic-vs-NonDiabetic
1.795550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.275600E-01
Normal-vs-NoPancreatitis
5.351600E-01
Pancreatitis-vs-NoPancreatitis
5.058400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.620600E-01
Normal-vs-N1
5.522800E-01
N0-vs-N1
5.812200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.427800E-01
Normal-vs-TP53-NonMutant
5.855400E-01
TP53-Mutant-vs-TP53-NonMutant
1.017780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
